MedTrace Logo

Comparative Effectiveness of Pregnancy Failure Management Regimens

NCT02012491 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2019-07-18

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to compare the effectiveness of combination treatment (mifepristone premedication plus single-dose misoprostol) to single-dose misoprostol (standard of care) for the management of early pregnancy failure.

Conditions

  • Spontaneous Abortion

Interventions

DRUG

Misoprostol

DRUG

Mifepristone

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • University of Pennsylvania

    lead OTHER

Principal Investigators

  • Courtney A Schreiber, MD, MPH · University of Pennsylvania

  • Mitchell Creinin, MD · University of California, Davis

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2017-05-15
Completion
2019-06-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02012491 on ClinicalTrials.gov